Clin2
NCT07756957Possibly a fitNot yet recruiting

Acne mRNA vaccine safety in teenagers

Acne

Part of Skin clinical trials.

This trial studies a new mRNA vaccine to see how safe it is for teenagers with moderate to severe acne. If your teen qualifies, they may receive the vaccine in either a low or high dose, while researchers monitor for side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
410 people
Ages
12 years to 17 years
Study type
Interventional

Who can take part

  • Age between 12 and 17 years.
  • Healthy overall, with no serious medical conditions.
  • Moderate or severe acne on the face, with enough pimples and blackheads.
  • No use of certain acne treatments without an appropriate break.
  • No weakened immune system or recent immunosuppressive therapy.
  • No known allergy to vaccine components or previous C. acnes vaccine.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06316297Recruiting· Phase 1/Phase 2
Testing a new mRNA vaccine for moderate to severe acne

This study tests an experimental mRNA vaccine designed to help the immune system fight acne-causing bacteria. It's for adults with moderate or severe facial acne who are otherwise healthy, and it may offer a new way to treat acne beyond typical creams or pills.

Scottsdale, Arizona
NCT07013747Recruiting· Phase 1/Phase 2
Acne mRNA vaccine for mild acne

This trial tests an mRNA vaccine designed to treat mild facial acne. It aims to see if the vaccine is safe and effective at reducing acne lesions.

Encino, California
NCT06716398Recruiting
A cosmetic study for teens and young adults with acne

This study tests a cosmetic product alongside a standard prescription acne treatment for 12 weeks, then a maintenance phase to see if the product helps improve acne and skin appearance.

São Paulo
NCT06989840Recruiting· Phase 1
Safety study of TVB-3567 for acne

This early-stage study tests a new drug called TVB-3567, which may help treat acne. It checks the drug's safety and how the body processes it, first in healthy people and then in people with moderate to severe acne.

Tempe, Arizona
NCT07411638Not yet recruiting
Acne skin and blood study for ages 18 to 25

This study looks at skin swabs and blood samples from people with different levels of acne to better understand the condition. You won't receive any new treatment, but you'll help researchers learn more about acne.

NCT03465150Recruiting
People with acne can join an acne patient study

This study creates a group (cohort) of patients treated for acne at a hospital to better understand acne care in real life. It may help improve future care by sharing what treatments people receive and how they do over time.

Nantes

Hear when a new Acne trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.